IL6 and pancreatic neoplasm: Indeed, epigenetic activation of this super-enhancer, as judged by Assay for Transposase-Accessible Chromatin (ATAC) sequencing signals, correlated with IL-6 expression in patients with esophageal and pancreatic cancers.